Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anlon Healthcare's gross profit for the
three
months ended in Jun. 2026 was ₹215 Mil. Anlon Healthcare's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was ₹793 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Anlon Healthcare's gross profit for the
three
months ended in Jun. 2026 was ₹215 Mil. Anlon Healthcare's Revenue for the
three
months ended in Jun. 2026 was ₹876 Mil. Therefore, Anlon Healthcare's Gross Margin % for the quarter that ended in Jun. 2026 was 24.53%.
Anlon Healthcare had a gross margin of 24.53% for the quarter that ended in Jun. 2026 => Competition eroding margins
During the past 5 years, the highestGross Margin % of Anlon Healthcare was 45.26%. The lowest was 21.68%. And the median was 37.25%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Anlon Healthcare had a gross margin of 24.53% for the quarter that ended in Jun. 2026 => Competition eroding margins
Anlon Healthcare Gross Profit Related Terms
Anlon Healthcare Gross Profit Historical Data
* Premium members only.
The historical data trend for Anlon Healthcare's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anlon Healthcare's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anlon Healthcare Gross Profit vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anlon Healthcare's Gross Profit distribution charts can be found below:
* The bar in red indicates where Anlon Healthcare's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹793 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Anlon Healthcare (NSE:AHCL) has a Gross Profit of ₹793 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Gross Profit too high?
Anlon Healthcare's current Gross Profit is ₹793 Mil. Overall, Anlon Healthcare has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Gross Profit compare to ZTS?
Anlon Healthcare's Gross Profit of ₹793 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Gross Profit is ₹793 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Gross Profit of ₹793 Mil. The current Gross Profit is ₹793 Mil. Anlon Healthcare's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Gross Profit is ₹793 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
21GF Score
Get the complete analysis for NSE:AHCL
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
